For the year ending 2025-12-31, ACRV has $129,717K in assets. $17,201K in debts. $41,499K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 41,499 | |||
| Short-term investments | 77,083 | |||
| Prepaid expenses and other current assets | 1,863 | |||
| Total current assets | 120,445 | |||
| Total property and equipment | 8,207 | |||
| Less accumulated depreciation | 3,318 | |||
| Property and equipment, net | 4,889 | |||
| Operating lease right-of-use assets | 2,527 | |||
| Restricted cash | 203 | |||
| Other assets | 1,653 | |||
| Total assets | 129,717 | |||
| Accounts payable | 2,277 | |||
| Accrued expenses and other current liabilities | 12,215 | |||
| Operating lease liabilities, current | 1,172 | |||
| Total current liabilities | 15,664 | |||
| Operating lease liabilities, non-current | 1,537 | |||
| Total liabilities | 17,201 | |||
| Common stock, 0.001 par value 500,000,000 shares authorized as of december 31, 2025 and 2024 31,648,856 and 31,231,264 shares issued and outstanding as of december 31, 2025 and 2024, respectively | 31 | |||
| Additional paid-in capital | 387,255 | |||
| Accumulated other comprehensive income | 111 | |||
| Accumulated deficit | -274,881 | |||
| Total stockholders' equity | 112,516 | |||
| Total liabilities and stockholders' equity | 129,717 | |||
Acrivon Therapeutics, Inc. (ACRV)
Acrivon Therapeutics, Inc. (ACRV)